US market entry Bridge Investment Fund specializes in Israeli medical device companies seeking US validation and US sales and marketing acceleration, presenting opportunities to connect portfolio firms with US market access and commercialization support.

Healthcare ecosystem With a focus on synergies with leading health care institutions in Cleveland, there is potential to partner for strategic pilots, clinical validation pathways, and access to hospital networks for portfolio companies.

Cross-border reach Dual offices in Cleveland and Tel Aviv enable bridging Israel's medical device innovation with US investors and customers, suggesting introductions to Israeli developers seeking US deployment and co-sell opportunities.

Early-stage readiness Portfolio targets have completed initial clinical trials, indicating readiness for late-stage discussions, regulatory alignment, and onboarding of US sales teams, which can be paced through Bridge's network.

Low-volume, high-potential With a lean team and sub-$1M revenue profile, Bridge represents an agile sourcing partner for early-stage medical device deals and co-investment opportunities with larger PE/VC firms seeking diverse, Israel-origin assets.